Antileishmanial Activity of Selected Turkish Medicinal Plants
dc.contributor.author | Ozbilgin, Ahmet | |
dc.contributor.author | Durmuskahya, Cenk | |
dc.contributor.author | Kayalar, Husniye | |
dc.contributor.author | Ertabaklar, Hatice | |
dc.contributor.author | Gunduz, Cumhur | |
dc.contributor.author | Ural, Ipek Ostan | |
dc.contributor.author | Zeyrek, Fadile | |
dc.contributor.author | Kurt, Ozgur | |
dc.contributor.author | Cavus, Ibrahim | |
dc.contributor.author | Balcioglu, Cuneyt | |
dc.contributor.author | Toz, Seray Ozensoy | |
dc.contributor.author | Ozbel, Yusuf | |
dc.date.accessioned | 2023-02-21T12:39:22Z | |
dc.date.available | 2023-02-21T12:39:22Z | |
dc.date.issued | 2014-01-01 | |
dc.description.abstract | Purpose: To determine the in vitro and in vivo anti-leishmanial activities of extracts obtained from Centaurea calolepis, Phlomis lycia, Eryngium thorifolium, Origanum sipyleum and Galium incanum ssp. centrale. Methods: To estimate the cytotoxicity of plant extracts, WST-1 assay was used. Parasite inhibition in the presence of plant extracts (25 - 500 mu g/ml) in comparision with control group and reference group (glucantime, 25 mu g/ml) at 12 - 72 h were determined in vitro on L. tropica promastigotes. The in vivo leishmanicidal activity of the extracts was evaluated against L. tropica-infected mice with glucantime as reference drug. Results: The chloroform extract of Galium incanum ssp. centrale showed the highest cytotoxicity with IC50 value of 0.0316 +/- 0.005 mu g/ml. In vitro parasite inhibition by the plant extracts ranged between 16.7 +/- 0.01 \% and 100 +/- 0.00 \% at 25 mu g/ml concentration. The methanol extract of Eryngium thorifolium possessed the highest activity on promastigotes of L. tropica with 100 \% inhibition at 25 mu g/ml. The water and chloroform extracts of C. calolepis and water and methanol extracts of E. thorifolium at a dose of 100 mg/kg reduced parasitaemia in L. tropica infected mice. Conclusion: Parasite viability results suggest that the methanol extract of Eryngium thorifolium, regarded as non-cytotoxic, is a promising candidate drug for treating L. tropica infection. | |
dc.description.issue | 12 | |
dc.description.issue | DEC | |
dc.description.pages | 2047-2055 | |
dc.description.volume | 13 | |
dc.identifier.doi | 10.4314/tjpr.v13i12.15 | |
dc.identifier.uri | https://hdl.handle.net/11443/2500 | |
dc.identifier.uri | http://dx.doi.org/10.4314/tjpr.v13i12.15 | |
dc.identifier.wos | WOS:000350412700015 | |
dc.publisher | PHARMACOTHERAPY GROUP | |
dc.relation.ispartof | TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH | |
dc.subject | Leishmaniasis | |
dc.subject | Leishmania tropica | |
dc.subject | Eryngium thorifolium | |
dc.subject | Promastigote | |
dc.subject | WI-38 Human fibroblasts | |
dc.title | Antileishmanial Activity of Selected Turkish Medicinal Plants | |
dc.type | Article |